Publications
-
Evaluation of the novel USPIO GEH121333 for MR imaging of cancer immune responses.
Shi Q,
Pisani LJ, Lee YK, Messing S, Ansari C, Bhaumik S, Lowery L, Lee BD, Meyer DE, Daldrup-Link HE.
Contrast Media Mol Imaging.
2013;
8
(3):
281-8
-
Ferumoxytol: a new, clinically applicable label for stem-cell tracking in arthritic joints with MRI.
Khurana A,
Nejadnik H, Chapelin F, Lenkov O, Gawande R, Lee S, Gupta SN, Aflakian N, Derugin N, Messing S, Lin G, Lue TF, Pisani L, Daldrup-Link HE.
Nanomedicine (Lond).
2013
-
Differentiation of normal thymus from anterior mediastinal lymphoma and lymphoma recurrence at pediatric PET/CT.
Gawande RS,
Khurana A, Messing S, Zhang D, Castañeda RT, Goldsby RE, Hawkins RA, Daldrup-Link HE.
Radiology.
2012;
262
(2):
613-22
-
Intravenous ferumoxytol allows noninvasive MR imaging monitoring of macrophage migration into stem cell transplants.
Khurana A,
Nejadnik H, Gawande R, Lin G, Lee S, Messing S, Castaneda R, Derugin N, Pisani L, Lue TF, Daldrup-Link HE.
Radiology.
2012;
264
(3):
803-11
-
Somatic differentiation and MR imaging of magnetically labeled human embryonic stem cells.
Nejadnik H,
Henning TD, Castaneda RT, Boddington S, Taubert S, Jha P, Tavri S, Golovko D, Ackerman L, Meier R, Daldrup-Link HE.
Cell Transplant.
2012;
21
(12):
2555-67
-
MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles.
Daldrup-Link HE,
Golovko D, Ruffell B, Denardo DG, Castaneda R, Ansari C, Rao J, Tikhomirov GA, Wendland MF, Corot C, Coussens LM.
Clin Cancer Res.
2011;
17
(17):
5695-704
-
Comparison of the diagnostic value of MR imaging and ophthalmoscopy for the staging of retinoblastoma.
Khurana A,
Eisenhut CA, Wan W, Ebrahimi KB, Patel C, O'Brien JM, Yeom K, Daldrup-Link HE.
Eur Radiol.
2013;
23
(5):
1271-80
-
Role of diffusion-weighted imaging in differentiating benign and malignant pediatric abdominal tumors.
Gawande RS,
Gonzalez G, Messing S, Khurana A, Daldrup-Link HE.
Pediatr Radiol.
2013
-
High-resolution MR imaging of the orbit in patients with retinoblastoma.
Rauschecker AM,
Patel CV, Yeom KW, Eisenhut CA, Gawande RS, O'Brien JM, Ebrahimi KB, Daldrup-Link HE.
Radiographics.
2012 Sep-Oct;
32
(5):
1307-26
-
Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial.
Matthay KK,
Weiss B, Villablanca JG, Maris JM, Yanik GA, Dubois SG, Stubbs J, Groshen S, Tsao-Wei D, Hawkins R, Jackson H, Goodarzian F, Daldrup-Link H, Panigrahy A, Towbin A, Shimada H, Barrett J, Lafrance N, Babich J.
J Nucl Med.
2012;
53
(7):
1155-63
-
Engineering stem cells for treatment of osteochondral defects.
Nejadnik H,
Daldrup-Link HE.
Skeletal Radiol.
2012;
41
(1):
1-4
-
MR imaging features of gadofluorine-labeled matrix-associated stem cell implants in cartilage defects.
Nejadnik H,
Henning TD, Do T, Sutton EJ, Baehner F, Horvai A, Sennino B, McDonald D, Meier R, Misselwitz B, Link TM, Daldrup-Link HE.
PLoS One.
2012;
7
(12):
e49971
-
MR imaging of tumor-associated macrophages.
Daldrup-Link H,
Coussens LM.
Oncoimmunology.
2012;
1
(4):
507-509
-
Magnetic resonance imaging of ferumoxide-labeled mesenchymal stem cells in cartilage defects: in vitro and in vivo investigations.
Henning TD,
Gawande R, Khurana A, Tavri S, Mandrussow L, Golovko D, Horvai A, Sennino B, McDonald D, Meier R, Wendland M, Derugin N, Link TM, Daldrup-Link HE.
Mol Imaging.
2012;
11
(3):
197-209
-
Depicting adoptive immunotherapy for prostate cancer in an animal model with magnetic resonance imaging.
Meier R,
Golovko D, Tavri S, Henning TD, Knopp C, Piontek G, Rudelius M, Heinrich P, Wels WS, Daldrup-Link H.
Magn Reson Med.
2011;
65
(3):
756-63
-
Labeling human embryonic stem-cell-derived cardiomyocytes for tracking with MR imaging.
Castaneda RT,
Boddington S, Henning TD, Wendland M, Mandrussow L, Liu S, Daldrup-Link H.
Pediatr Radiol.
2011;
41
(11):
1384-92
-
Labeling human mesenchymal stem cells with fluorescent contrast agents: the biological impact.
Boddington SE,
Sutton EJ, Henning TD, Nedopil AJ, Sennino B, Kim A, Daldrup-Link HE.
Mol Imaging Biol.
2011;
13
(1):
3-9
-
Labeling stem cells with ferumoxytol, an FDA-approved iron oxide nanoparticle.
Castaneda RT,
Khurana A, Khan R, Daldrup-Link HE.
J Vis Exp.
2011;
(57):
e3482
-
Optical imaging of rheumatoid arthritis.
Golovko D,
Meier R, Rummeny E, Daldrup-Link H.
Int J Clin Rheumtol.
2011;
6
(1):
67-75
-
Accelerated stem cell labeling with ferucarbotran and protamine.
Golovko DM,
Henning T, Bauer JS, Settles M, Frenzel T, Mayerhofer A, Rummeny EJ, Daldrup-Link HE.
Eur Radiol.
2010;
20
(3):
640-8
-
Breast cancers: MR imaging of folate-receptor expression with the folate-specific nanoparticle P1133.
Meier R,
Henning TD, Boddington S, Tavri S, Arora S, Piontek G, Rudelius M, Corot C, Daldrup-Link HE.
Radiology.
2010;
255
(2):
527-35
-
Ectopic ureter associated with uterine didelphys and obstructed hemivagina: preoperative diagnosis by MRI.
Wang ZJ,
Daldrup-Link H, Coakley FV, Yeh BM.
Pediatr Radiol.
2010;
40
(3):
358-60
-
Implantation of ferumoxides labeled human mesenchymal stem cells in cartilage defects.
Nedopil AJ,
Mandrussow LG, Daldrup-Link HE.
J Vis Exp.
2010;
(38)
-
In vivo magnetic resonance imaging and optical imaging comparison of viable and nonviable mesenchymal stem cells with a bifunctional label.
Sutton EJ,
Henning TD, Boddington S, Demos S, Krug C, Meier R, Kornak J, Zhao S, Baehner R, Sharifi S, Daldrup-Link H.
Mol Imaging.
2010;
9
(5):
278-90
-
Indocyanine green-enhanced imaging of antigen-induced arthritis with an integrated optical imaging/radiography system.
Meier R,
Krug C, Golovko D, Boddington S, Piontek G, Rudelius M, Sutton EJ, Baur-Melnyk A, Jones EF, Daldrup-Link HE.
Arthritis Rheum.
2010;
62
(8):
2322-7
-
Labeling human embryonic stem cell-derived cardiomyocytes with indocyanine green for noninvasive tracking with optical imaging: an FDA-compatible alternative to firefly luciferase.
Boddington SE,
Henning TD, Jha P, Schlieve CR, Mandrussow L, DeNardo D, Bernstein HS, Ritner C, Golovko D, Lu Y, Zhao S, Daldrup-Link HE.
Cell Transplant.
2010;
19
(1):
55-65
-
MR signal characteristics of viable and apoptotic human mesenchymal stem cells in matrix-associated stem cell implants for treatment of osteoarthritis.
Nedopil A,
Klenk C, Kim C, Liu S, Wendland M, Golovko D, Schuster T, Sennino B, McDonald DM, Daldrup-Link HE.
Invest Radiol.
2010;
45
(10):
634-40
-
Monitoring of natural killer cell immunotherapy using noninvasive imaging modalities.
Jha P,
Golovko D, Bains S, Hostetter D, Meier R, Wendland MF, Daldrup-Link HE.
Cancer Res.
2010;
70
(15):
6109-13
-
Radiological-pathological correlation of pleomorphic liposarcoma of the anterior mediastinum in a 17-year-old girl.
Saeed M,
Plett S, Kim GE, Daldrup-Link H, Courtier J.
Pediatr Radiol.
2010:
40 Suppl 1
S68-70
-
Unusual association of alveolar rhabdomyosarcoma with pancreatic metastasis: emerging role of PET-CT in tumor staging.
Jha P,
Frölich AM, McCarville B, Navarro OM, Babyn P, Goldsby R, Daldrup-Link H.
Pediatr Radiol.
2010;
40
(8):
1380-6
-
The influence of ferucarbotran on the chondrogenesis of human mesenchymal stem cells.
Henning TD,
Sutton EJ, Kim A, Golovko D, Horvai A, Ackerman L, Sennino B, McDonald D, Lotz J, Daldrup-Link HE.
Contrast Media Mol Imaging.
2009 Jul-Aug;
4
(4):
165-73
-
Optical imaging of cellular immunotherapy against prostate cancer.
Tavri S,
Jha P, Meier R, Henning TD, Müller T, Hostetter D, Knopp C, Johansson M, Reinhart V, Boddington S, Sista A, Wels WS, Daldrup-Link HE.
Mol Imaging.
2009 Jan-Feb;
8
(1):
15-26
-
An optical imaging method to monitor stem cell migration in a model of immune-mediated arthritis.
Sutton EJ,
Boddington SE, Nedopil AJ, Henning TD, Demos SG, Baehner R, Sennino B, Lu Y, Daldrup-Link HE.
Opt Express.
2009;
17
(26):
24403-13
-
Decreased aortic growth and middle aortic syndrome in patients with neuroblastoma after radiation therapy.
Sutton EJ,
Tong RT, Gillis AM, Henning TD, Weinberg VA, Boddington S, Haas-Kogan DA, Matthay K, Sha V, Gooding C, Coakley FV, Daldrup-Link H.
Pediatr Radiol.
2009;
39
(11):
1194-202
-
Diagnostic value of PET/CT for the staging and restaging of pediatric tumors.
Kleis M,
Daldrup-Link H, Matthay K, Goldsby R, Lu Y, Schuster T, Schreck C, Chu PW, Hawkins RA, Franc BL.
Eur J Nucl Med Mol Imaging.
2009;
36
(1):
23-36
-
MR imaging of pediatric arthritis.
Daldrup-Link HE,
Steinbach L.
Magn Reson Imaging Clin N Am.
2009;
17
(3):
451-67, vi
-
New perspectives on bone marrow contrast agents and molecular imaging.
Daldrup-Link HE,
Mohanty A, Cuenod C, Pichler B, Link T.
Semin Musculoskelet Radiol.
2009;
13
(2):
145-56
-
Optical imaging of the peri-tumoral inflammatory response in breast cancer.
Sista AK,
Knebel RJ, Tavri S, Johansson M, DeNardo DG, Boddington SE, Kishore SA, Ansari C, Reinhart V, Coakley FV, Coussens LM, Daldrup-Link HE.
J Transl Med.
2009:
7
94
-
Pediatric liver tumors--a pictorial review.
Jha P,
Chawla SC, Tavri S, Patel C, Gooding C, Daldrup-Link H.
Eur Radiol.
2009;
19
(1):
209-19
-
Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study.
Wagner LM,
Villablanca JG, Stewart CF, Crews KR, Groshen S, Reynolds CP, Park JR, Maris JM, Hawkins RA, Daldrup-Link HE, Jackson HA, Matthay KK.
J Clin Oncol.
2009;
27
(8):
1290-6
-
Relaxation effects of ferucarbotran-labeled mesenchymal stem cells at 1.5T and 3T: discrimination of viable from lysed cells.
Henning TD,
Wendland MF, Golovko D, Sutton EJ, Sennino B, Malek F, Bauer JS, McDonald DM, Daldrup-Link H.
Magn Reson Med.
2009;
62
(2):
325-32
-
Improved fluorescence of indocyanine green in vitro and in vivo after simple cooling procedures.
Boddington S,
Sutton EJ, Jones E, Purcell DD, Henning TD, Tavri S, Meier R, Sista A, Fu Y, Daldrup-Link H.
Contrast Media Mol Imaging.
2008 Sep-Oct;
3
(5):
191-7
-
Cell tracking with optical imaging.
Sutton EJ,
Henning TD, Pichler BJ, Bremer C, Daldrup-Link HE.
Eur Radiol.
2008;
18
(10):
2021-32
-
Detection of postoperative granulation tissue with an ICG-enhanced integrated OI-/X-ray System.
Meier R,
Boddington S, Krug C, Acosta FL, Thullier D, Henning TD, Sutton EJ, Tavri S, Lotz JC, Daldrup-Link HE.
J Transl Med.
2008:
6
73
-
Imaging characteristics of DHOG, a hepatobiliary contrast agent for preclinical microCT in mice.
Henning T,
Weber AW, Bauer JS, Meier R, Carlsen JM, Sutton EJ, Prevrhal S, Ziegler SI, Feussner H, Daldrup-Link HE, Rummeny EJ.
Acad Radiol.
2008;
15
(3):
342-9
-
Labeling hESCs and hMSCs with iron oxide nanoparticles for non-invasive in vivo tracking with MR imaging.
Henning TD,
Boddington S, Daldrup-Link HE.
J Vis Exp.
2008;
(13)
-
Labeling stem cells with fluorescent dyes for non-invasive detection with optical imaging.
Boddington S,
Henning TD, Sutton EJ, Daldrup-Link HE.
J Vis Exp.
2008;
(14)
-
MR imaging of ovarian tumors using folate-receptor-targeted contrast agents.
Wang ZJ,
Boddington S, Wendland M, Meier R, Corot C, Daldrup-Link H.
Pediatr Radiol.
2008;
38
(5):
529-37
-
Receptor imaging of pediatric tumors: clinical practice and new developments.
Daldrup-Link HE,
Hawkins RA, Meier R, Goldsby RE, Artemov D.
Pediatr Radiol.
2008;
38
(11):
1154-61
-
Tracking of [18F]FDG-labeled natural killer cells to HER2/neu-positive tumors.
Meier R,
Piert M, Piontek G, Rudelius M, Oostendorp RA, Senekowitsch-Schmidtke R, Henning TD, Wels WS, Uherek C, Rummeny EJ, Daldrup-Link HE.
Nucl Med Biol.
2008;
35
(5):
579-88
-
MR imaging of antigen-induced arthritis with a new, folate receptor-targeted contrast agent.
Saborowski O,
Simon GH, Raatschen HJ, Wendland MF, Fu Y, Henning T, Baehner R, Corot C, Chen MH, Daldrup-Link HE.
Contrast Media Mol Imaging.
2007 Mar-Apr;
2
(2):
72-81
-
Cell labeling with the positive MR contrast agent Gadofluorine M.
Henning TD,
Saborowski O, Golovko D, Boddington S, Bauer JS, Fu Y, Meier R, Pietsch H, Sennino B, McDonald DM, Daldrup-Link HE.
Eur Radiol.
2007;
17
(5):
1226-34
-
Long-term outcome and toxicities of intraoperative radiotherapy for high-risk neuroblastoma.
Gillis AM,
Sutton E, Dewitt KD, Matthay KK, Weinberg V, Fisch BM, Chan A, Gooding C, Daldrup-Link H, Wara WM, Farmer DL, Harrison MR, Haas-Kogan D.
Int J Radiat Oncol Biol Phys.
2007;
69
(3):
858-64
-
MR imaging of therapy-induced changes of bone marrow.
Daldrup-Link HE,
Henning T, Link TM.
Eur Radiol.
2007;
17
(3):
743-61
-
[Macrophage specific MRI imaging for antigen induced arthritides. A potential new strategy for the diagnosis of rheumatoid arthritis].
Simon GH,
Daldrup-Link HE, Rummeny EJ.
Radiologe.
2007;
47
(1):
43-52
-
Ferumoxtran-10-enhanced MR imaging of the bone marrow before and after conditioning therapy in patients with non-Hodgkin lymphomas.
Metz S,
Lohr S, Settles M, Beer A, Woertler K, Rummeny EJ, Daldrup-Link HE.
Eur Radiol.
2006;
16
(3):
598-607
-
Imaging of tumor angiogenesis: current approaches and future prospects.
Daldrup-Link HE,
Simon GH, Brasch RC.
Curr Pharm Des.
2006;
12
(21):
2661-72
-
MRI of arthritis: comparison of ultrasmall superparamagnetic iron oxide vs. Gd-DTPA.
Simon GH,
von Vopelius-Feldt J, Wendland MF, Fu Y, Piontek G, Schlegel J, Chen MH, Daldrup-Link HE.
J Magn Reson Imaging.
2006;
23
(5):
720-7
-
Optical imaging of experimental arthritis using allogeneic leukocytes labeled with a near-infrared fluorescent probe.
Simon GH,
Daldrup-Link HE, Kau J, Metz S, Schlegel J, Piontek G, Saborowski O, Demos S, Duyster J, Pichler BJ.
Eur J Nucl Med Mol Imaging.
2006;
33
(9):
998-1006
-
T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning.
Simon GH,
Bauer J, Saborovski O, Fu Y, Corot C, Wendland MF, Daldrup-Link HE.
Eur Radiol.
2006;
16
(3):
738-45
-
Ultrasmall supraparamagnetic iron oxide-enhanced magnetic resonance imaging of antigen-induced arthritis: a comparative study between SHU 555 C, ferumoxtran-10, and ferumoxytol.
Simon GH,
von Vopelius-Feldt J, Fu Y, Schlegel J, Pinotek G, Wendland MF, Chen MH, Daldrup-Link HE.
Invest Radiol.
2006;
41
(1):
45-51
-
[MRI of arthritis with the USPIO SH U 555 C: optimization of T1 enhancement].
Simon G,
Daldrup-Link H, von Vopelius-Feldt J, Wendland M, Fu Y, Schlegel J, Rummeny E.
Rofo.
2006;
178
(2):
200-6
-
Comparison of iron oxide labeling properties of hematopoietic progenitor cells from umbilical cord blood and from peripheral blood for subsequent in vivo tracking in a xenotransplant mouse model XXX.
Daldrup-Link HE,
Rudelius M, Oostendorp RA, Jacobs VR, Simon GH, Gooding C, Rummeny EJ.
Acad Radiol.
2005;
12
(4):
502-10
-
Detection of hepatocellular carcinoma: comparison of Gd-DTPA- and ferumoxides-enhanced MR imaging.
Simon G,
Link TM, Wörtler K, Doebereiner F, Schulte-Frohlinde E, Daldrup-Link H, Settles M, Rummeny EJ.
Eur Radiol.
2005;
15
(5):
895-903
-
In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging.
Daldrup-Link HE,
Meier R, Rudelius M, Piontek G, Piert M, Metz S, Settles M, Uherek C, Wels W, Schlegel J, Rummeny EJ.
Eur Radiol.
2005;
15
(1):
4-13
-
Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment.
Daldrup-Link HE,
Rudelius M, Piontek G, Metz S, Bräuer R, Debus G, Corot C, Schlegel J, Link TM, Peschel C, Rummeny EJ, Oostendorp RA.
Radiology.
2005;
234
(1):
197-205
-
Mixture model approach to tumor classification based on pharmacokinetic measures of tumor permeability.
Spilker ME,
Seng KY, Yao AA, Daldrup-Link HE, Shames DM, Brasch RC, Vicini P.
J Magn Reson Imaging.
2005;
22
(4):
549-58
-
Optimization of gadodiamide concentration for MR arthrography at 3 T.
Masi JN,
Newitt D, Sell CA, Daldrup-Link H, Steinbach L, Majumdar S, Link TM.
AJR Am J Roentgenol.
2005;
184
(6):
1754-61
-
The choice of region of interest measures in contrast-enhanced magnetic resonance image characterization of experimental breast tumors.
Preda A,
Turetschek K, Daldrup H, Floyd E, Novikov V, Shames DM, Roberts TP, Carter WO, Brasch RC.
Invest Radiol.
2005;
40
(6):
349-54
-
Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research.
Simon GH,
Raatschen HJ, Wendland MF, von Vopelius-Feldt J, Fu Y, Chen MH, Daldrup-Link HE.
Acad Radiol.
2005;
12
(9):
1190-7
-
Decrease in tumor apparent permeability-surface area product to a MRI macromolecular contrast medium following angiogenesis inhibition with correlations to cytotoxic drug accumulation.
Daldrup-Link HE,
Okuhata Y, Wolfe A, Srivastav S, Øie S, Ferrara N, Cohen RL, Shames DM, Brasch RC.
Microcirculation.
2004 Jul-Aug;
11
(5):
387-96
-
Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro.
Metz S,
Bonaterra G, Rudelius M, Settles M, Rummeny EJ, Daldrup-Link HE.
Eur Radiol.
2004;
14
(10):
1851-8
-
Cell tracking with gadophrin-2: a bifunctional contrast agent for MR imaging, optical imaging, and fluorescence microscopy.
Daldrup-Link HE,
Rudelius M, Metz S, Piontek G, Pichler B, Settles M, Heinzmann U, Schlegel J, Oostendorp RA, Rummeny EJ.
Eur J Nucl Med Mol Imaging.
2004;
31
(9):
1312-21
-
Highly efficient paramagnetic labelling of embryonic and neuronal stem cells.
Rudelius M,
Daldrup-Link HE, Heinzmann U, Piontek G, Settles M, Link TM, Schlegel J.
Eur J Nucl Med Mol Imaging.
2003;
30
(7):
1038-44
-
Macromolecular contrast agents for MR mammography: current status.
Daldrup-Link HE,
Brasch RC.
Eur Radiol.
2003;
13
(2):
354-65
-
Macromolecular contrast medium (feruglose) versus small molecular contrast medium (gadopentetate) enhanced magnetic resonance imaging: differentiation of benign and malignant breast lesions.
Daldrup-Link HE,
Kaiser A, Helbich T, Werner M, Bjørnerud A, Link TM, Rummeny EJ.
Acad Radiol.
2003;
10
(11):
1237-46
-
Quantification of breast tumor microvascular permeability with feruglose-enhanced MR imaging: initial phase II multicenter trial.
Daldrup-Link HE,
Rydland J, Helbich TH, Bjørnerud A, Turetschek K, Kvistad KA, Kaindl E, Link TM, Staudacher K, Shames D, Brasch RC, Haraldseth O, Rummeny EJ.
Radiology.
2003;
229
(3):
885-92
-
Targeting of hematopoietic progenitor cells with MR contrast agents.
Daldrup-Link HE,
Rudelius M, Oostendorp RA, Settles M, Piontek G, Metz S, Rosenbrock H, Keller U, Heinzmann U, Rummeny EJ, Schlegel J, Link TM.
Radiology.
2003;
228
(3):
760-7
-
Comparison between gadopentetate and feruglose (Clariscan)-enhanced MR-mammography: preliminary clinical experience.
Daldrup-Link HE,
Kaiser A, Link TM, Settles M, Helbich T, Werner M, Roberts TP, Rummeny EJ.
Acad Radiol.
2002:
9 Suppl 2
S343-7
-
FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging.
Franzius C,
Daldrup-Link HE, Wagner-Bohn A, Sciuk J, Heindel WL, Jürgens H, Schober O.
Ann Oncol.
2002;
13
(1):
157-60
-
Iron-oxide-enhanced MR imaging of bone marrow in patients with non-Hodgkin's lymphoma: differentiation between tumor infiltration and hypercellular bone marrow.
Daldrup-Link HE,
Rummeny EJ, Ihssen B, Kienast J, Link TM.
Eur Radiol.
2002;
12
(6):
1557-66
-
[Atypical mycobacteriosis of the breast: MR diagnosis].
Kaiser A,
Werner M, Daldrup-Link HE.
Rofo.
2002;
174
(2):
236-7
-
Carboxymethyldextran-A2-Gd-DOTA enhancement patterns in the abdomen and pelvis in an animal model.
Daldrup-Link HE,
Link TM, Möller HE, Wiedermann D, Bonnemain B, Corot C, Rummeny EJ.
Eur Radiol.
2001;
11
(7):
1276-84
-
FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT.
Franzius C,
Daldrup-Link HE, Sciuk J, Rummeny EJ, Bielack S, Jürgens H, Schober O.
Ann Oncol.
2001;
12
(4):
479-86
-
Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET.
Daldrup-Link HE,
Franzius C, Link TM, Laukamp D, Sciuk J, Jürgens H, Schober O, Rummeny EJ.
AJR Am J Roentgenol.
2001;
177
(1):
229-36
-
[Experimental studies of the value of SPIO for MRI of bone marrow before and after whole body irradiation].
Daldrup-Link HE,
Reinländer C, Link TM, Richter KJ, Könemann S, Rummeny EJ.
Rofo.
2001;
173
(6):
547-53
-
CT of metal implants: reduction of artifacts using an extended CT scale technique.
Link TM,
Berning W, Scherf S, Joosten U, Joist A, Engelke K, Daldrup-Link HE.
J Comput Assist Tomogr.
2000 Jan-Feb;
24
(1):
165-72
-
Assessing permeability alterations of the blood-bone marrow barrier due to total body irradiation: in vivo quantification with contrast enhanced magnetic resonance imaging.
Daldrup-Link HE,
Link TM, Rummeny EJ, August C, Könemann S, Jürgens H, Heindel W.
Bone Marrow Transplant.
2000;
25
(1):
71-8
-
Comparison of Gadomer-17 and gadopentetate dimeglumine for differentiation of benign from malignant breast tumors with MR imaging.
Daldrup-Link HE,
Shames DM, Wendland M, Mühler A, Gossmann A, Rosenau W, Brasch RC.
Acad Radiol.
2000;
7
(11):
934-44
-
Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions.
Pirovano G,
Vanzulli A, Marti-Bonmati L, Grazioli L, Manfredi R, Greco A, Holzknecht N, Daldrup-Link HE, Rummeny E, Hamm B, Arneson V, Imperatori L, Kirchin MA, Spinazzi A.
AJR Am J Roentgenol.
2000;
175
(4):
1111-20
-
FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy.
Franzius C,
Sciuk J, Daldrup-Link HE, Jürgens H, Schober O.
Eur J Nucl Med.
2000;
27
(9):
1305-11
-
Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical study.
Petersein J,
Spinazzi A, Giovagnoni A, Soyer P, Terrier F, Lencioni R, Bartolozzi C, Grazioli L, Chiesa A, Manfredi R, Marano P, Van Persijn Van Meerten EL, Bloem JL, Petre C, Marchal G, Greco A, McNamara MT, Heuck A, Reiser M, Laniado M, Claussen C, Daldrup HE, Rummeny E, Kirchin MA, Pirovano G, Hamm B.
Radiology.
2000;
215
(3):
727-36
-
Quantitative gadopentetate-enhanced MRI of breast tumors: testing of different analytic methods.
Helbich TH,
Roberts TP, Gossmann A, Wendland MF, Shames DM, Adachi M, Yang S, Huber S, Daldrup H, Brasch RC.
Magn Reson Med.
2000;
44
(6):
915-24
-
Monitoring radiation-induced changes in bone marrow histopathology with ultra-small superparamagnetic iron oxide (USPIO)-enhanced MRI.
Daldrup HE,
Link TM, Blasius S, Strozyk A, Könemann S, Jürgens H, Rummeny EJ.
J Magn Reson Imaging.
1999;
9
(5):
643-52
-
Tumor blood volume assays using contrast-enhanced magnetic resonance imaging: regional heterogeneity and postmortem artifacts.
Okuhata Y,
Brasch RC, Pham CD, Daldrup H, Wendland MF, Shames DM, Roberts TP.
J Magn Reson Imaging.
1999;
9
(5):
685-90
-
Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media.
Daldrup H,
Shames DM, Wendland M, Okuhata Y, Link TM, Rosenau W, Lu Y, Brasch RC.
AJR Am J Roentgenol.
1998;
171
(4):
941-9
-
Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media.
Daldrup H,
Shames DM, Wendland M, Okuhata Y, Link TM, Rosenau W, Lu Y, Brasch RC.
Pediatr Radiol.
1998;
28
(2):
67-78
-
High resolution MRI of small joints: impact of spatial resolution on diagnostic performance and SNR.
Link TM,
Majumdar S, Peterfy C, Daldrup HE, Uffmann M, Dowling C, Steinbach L, Genant HK.
Magn Reson Imaging.
1998;
16
(2):
147-55
-
MR imaging of thoracic tumors in pediatric patients.
Daldrup HE,
Link TM, Wörtler K, Reimer P, Rummeny EJ.
AJR Am J Roentgenol.
1998;
170
(6):
1639-44
-
Macromolecular contrast media-enhanced MRI estimates of microvascular permeability correlate with histopathologic tumor grade.
Brasch RC,
Daldrup H, Shames D, Wendland M, Okuhata Y, Rosenau W.
Acad Radiol.
1998:
5 Suppl 1
S2-5
-
Quantification of the extraction fraction for gadopentetate across breast cancer capillaries.
Daldrup HE,
Shames DM, Husseini W, Wendland MF, Okuhata Y, Brasch RC.
Magn Reson Med.
1998;
40
(4):
537-43
-
Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging.
Reimer P,
Rummeny EJ, Daldrup HE, Hesse T, Balzer T, Tombach B, Peters PE.
Eur Radiol.
1997;
7
(2):
275-80
-
Evaluation of myelination and myelination disorders with turbo inversion recovery magnetic resonance imaging.
Daldrup HE,
Schuierer G, Link TM, Moeller H, Bick U, Kurlemann G, Peters PE.
Eur Radiol.
1997;
7
(9):
1478-84
-
[Macromolecular contrast media for MR mammography. A new approach to characterizing breast tumors].
Daldrup HE,
Roberts TP, Mühler A, Gossmann A, Roberts HC, Wendland M, Rosenau W, Brasch RC.
Radiologe.
1997;
37
(9):
733-40
-
Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.
Reimer P,
Rummeny EJ, Shamsi K, Balzer T, Daldrup HE, Tombach B, Hesse T, Berns T, Peters PE.
Radiology.
1996;
199
(1):
177-83
-
[High dosage Gd-DPTA-BMA (Gadodiamid) administration in diagnosis and therapeutic monitoring of malignant bone tumors].
Häussler MD,
Rummeny EJ, Raufhake C, Blasius S, Lindner N, Daldrup HE, Reimer P, Peters PE.
Radiologe.
1996;
36
(2):
148-52
-
[New MR contrast media in liver diagnosis. Initial clinical results with hepatobiliary Eovist (gadolinium-EOB-DTPA) and RES-specific Resovist (SH U 555 A)].
Reimer P,
Tombach B, Daldrup H, Hesse T, Sander G, Balzer T, Shamsi K, Berns T, Rummeny EJ, Peters PE.
Radiologe.
1996;
36
(2):
124-33
-
[Primary non-Hodgkin's lymphoma of the skull in an 11-year-old girl. Follow-up and review of the literature].
Daldrup HE,
Reimer P, Wolf KJ, Peters PE.
Radiologe.
1996;
36
(4):
354-9
-
[The value of 3-phase spiral CT and magnetic resonance tomography in preoperative diagnosis of pancreatic carcinoma].
Lentschig MG,
Reimer P, Rummeny E, Grenzheuser C, Daldrup HE, Berns T, Dinse P, Sulkowski U, Peters PE.
Radiologe.
1996;
36
(5):
406-12
-
[Use of gadoteridol in MR diagnosis of rheumatoid changes in the joints].
Link TM,
Bongartz GM, Böger K, Daldrup H, Schmitz-Linneweber B, Peters PE.
Radiologe.
1996;
36
(2):
141-7
-
Clinical results with Resovist: a phase 2 clinical trial.
Reimer P,
Rummeny EJ, Daldrup HE, Balzer T, Tombach B, Berns T, Peters PE.
Radiology.
1995;
195
(2):
489-96
-
[Detection of liver tumors].
Rummeny EJ,
Reimer P, Daldrup H, Peters PE.
Radiologe.
1995;
35
(11 Suppl 2):
S252-8
-
[New super-paramagnetic iron particles for MRI. Phase II study of malignant liver tumors].
Daldrup HE,
Reimer P, Rummeny EJ, Tombach B, Berns T, Balzer T, Schimpfky C, Peters PE.
Radiologe.
1995;
35
(8):
486-93
-
[The regression of a hepatocellular adenoma after the withdrawal of hormonal contraception].
Daldrup HE,
Reimer P, Rummeny EJ, Fischer H, Böcker W, Peters PE.
Rofo.
1995;
163
(5):
449-51
Navigation for This Section: Stanford Hospital & Clinics
Additional Links: Hospital Services
FIND A PHYSICIAN
Help